RAP1B and hepatocellular carcinoma: Since the aforementioned in vivo data suggested that Rap1b could be upregulated and activated during CaHEV infection, in vitro studies using hepatocellular carcinoma LMH cells with stable expression of OATP1A2 (LMH-1A2) were conducted to comprehensively verify the in vivo results.